Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEMZONE: Neoadjuvant Letrozole +/- Zoledronic Acid in Breast Cancer
NCT00375752Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jun 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in breast cancer, sponsored by Novartis. Started Jun 2006; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00375752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375752.